Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 2
2021 3
2022 4
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Results by year

Filters applied: . Clear all
Page 1
Treatment Settings and Outcomes with Regorafenib and Trifluridine/Tipiracil at Third-Line Treatment and beyond in Metastatic Colorectal Cancer: A Real-World Multicenter Retrospective Study.
Signorelli C, Calegari MA, Basso M, Anghelone A, Lucchetti J, Minelli A, Angotti L, Zurlo IV, Schirripa M, Chilelli MG, Morelli C, Dell'Aquila E, Cosimati A, Gemma D, Ribelli M, Emiliani A, Corsi DC, Arrivi G, Mazzuca F, Zoratto F, Morandi MG, Santamaria F, Saltarelli R, Ruggeri EM. Signorelli C, et al. Among authors: cosimati a. Curr Oncol. 2023 Jun 4;30(6):5456-5469. doi: 10.3390/curroncol30060413. Curr Oncol. 2023. PMID: 37366896 Free PMC article.
Duration of humoral response to the third dose of BNT162b2 vaccine in patients with solid cancer: Is fourth dose urgently needed?
Di Noia V, Pimpinelli F, Renna D, Campo F, Cosimati A, Torchia A, Marcozzi B, Massacci A, Pallocca M, Pellini R, Morrone A, Cognetti F. Di Noia V, et al. Among authors: cosimati a. Eur J Cancer. 2022 Nov;176:164-167. doi: 10.1016/j.ejca.2022.09.006. Epub 2022 Oct 9. Eur J Cancer. 2022. PMID: 36223679 Free PMC article. No abstract available.
The impact of the COVID-19 pandemic on diagnosis and treatment of patients with soft tissue and bone sarcomas or aggressive benign musculoskeletal diseases: A single-center retrospective study (SarCorD study).
Onesti CE, Vari S, Nardozza F, Maggi G, Minghelli D, Rossi B, Sperati F, Checcucci E, Faltyn W, Cercato MC, Cosimati A, Biagini R, Ciliberto G, Ferraresi V. Onesti CE, et al. Among authors: cosimati a. Front Oncol. 2022 Sep 20;12:1000056. doi: 10.3389/fonc.2022.1000056. eCollection 2022. Front Oncol. 2022. PMID: 36249051 Free PMC article.
Retrospective Correlation between First Drug Treatment Duration and Survival Outcomes in Sequential Treatment with Regorafenib and Trifluridine/Tipiracil in Refractory Metastatic Colorectal Cancer: A Real-World Subgroup Analysis.
Signorelli C, Chilelli MG, Giannarelli D, Basso M, Calegari MA, Anghelone A, Lucchetti J, Minelli A, Angotti L, Zurlo IV, Schirripa M, Morelli C, Dell'Aquila E, Cosimati A, Gemma D, Ribelli M, Emiliani A, Corsi DC, Arrivi G, Mazzuca F, Zoratto F, Morandi MG, Santamaria F, Saltarelli R, Ruggeri EM. Signorelli C, et al. Among authors: cosimati a. Cancers (Basel). 2023 Dec 8;15(24):5758. doi: 10.3390/cancers15245758. Cancers (Basel). 2023. PMID: 38136304 Free PMC article.
Quality of life and emotional distress in sarcoma patients diagnosed during COVID-19 pandemic: a supplementary analysis from the SarCorD study.
Onesti CE, Vari S, Minghelli D, Nardozza F, Rossi B, Sperati F, Checcucci E, Faltyn W, Cercato MC, Cosimati A, Salvatori F, Biagini R, Ciliberto G, Ferraresi V, Maggi G. Onesti CE, et al. Among authors: cosimati a. Front Psychol. 2023 Jun 2;14:1078992. doi: 10.3389/fpsyg.2023.1078992. eCollection 2023. Front Psychol. 2023. PMID: 37333608 Free PMC article.
12 results